avVaa World Health Care Products Receives Trademark on dermalustre(R) Professional Pet and Equine Skin & Coat Treatment

Sep 07, 2006, 01:00 ET from avVaa World Health Care Products Inc.

    LUMBY, British Columbia, Sept. 7 /PRNewswire-FirstCall/ -- avVaa World
 Health Care Products Inc. (OTC Bulletin Board:   AVVW), a global
 biotechnology company offering therapeutic, natural skin and health care
 products for human and animals, announced today that it has received a
 registered trademark for its proprietary dermalustre(R) professional pet
 and equine skin and coat treatment.
     avVaa EVP Sales and Marketing and Advisor to the Board Lorie
 Campbell-Farley, said, "We are pleased to announce the registration of
 dermalustre(R) as a registered trademark. Our product slogans in
 conjunction with our trademark: 'dermalustre(R), because you love your
 pet', and 'dermalustre(R), the heart of every champion,' will soon become
 highly recognizable in the pet and equine industries, as a result of our
 established advertising campaign and presence at upcoming trade shows that
 are expected to further secure avVaa in the Pet and Equine Industry.
     avVaa VP of Animal Care Barb Hazell said, "In helping to develop
 dermalustre(R) over the past three years, I am very proud and pleased to be
 able to offer the full line of avVaa Care products, including:
 dermalustre(R), dermaspray, dermabrite Conditioning Shampoo and
 dermahoof-fit, to the pet and equine markets."
     Hazell continued, "These products are now available at pet stores and
 tack shops across Canada and USA. Brand awareness of our dermalustre(R) is
 being built in ad campaigns that can now be found in retail magazines, such
 as: Pet Product News, Pet Age and Tack N Togs.
     "For our consumer, ads are also in magazines such as: Dogs in Canada,
 Modern Dog, Animal Wellness, Saddle Up, Horses All, Horse Sport, and Equine
     About dermalustre(R) Animal and Equine Professional Skin and Coat
     dermalustre(R) contains no waxes, silicone or harmful chemicals. Even
 when dermalustre(R) is applied to animal coats, its usage is safe for
 handlers, children and pets and horses. avVaa's dermalustre utilizes
 nanotechnology: a fine mineral solution that quickly absorbs into the skin
 and coat, providing deep conditioning and treatment, leaving no residue or
 build up. dermalustre(R) restores moisture to dry brittle coats and quickly
 relieves itchy, dry, flaky skin, while repelling dust and dirt. In
 addition, dermalustre(R) produces a healthy shine and it detangles! Visit
 www.naturesgroom.com for more information on this growing line of pet and
 equine care products.
     About avVaa World Health Care Products
     avVaa World Health Care Products (AVVW) is a global biotechnology
 company that specializes in effective, all natural, therapeutic skin care
 products that improve quality of life and well being for consumers. avVaa's
 patented European skin care formulas are scientifically registered,
 FDA-Compliant, and were developed to relieve and treat the symptoms of
 common skin ailments, including: eczema, psoriasis and acne. avVaa is
 poised to manufacture and market its OTC Neuroskin line of skin care
 products through mass food and drug channels in the United States and
     For additional information on avVaa contact Jack Farley CEO/Chairman,
 at 1-866-772-8822 or visit: www.avvaa.com or www.otcfn.com/avvw
     Investor Relations: Merle Goertz (West Coast) of avVaa World Health
 Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network,
 1-781-444-6100 ext. 625
     Safe Harbor: Statements contained in this press release that are not
 based upon current or historical fact are forward-looking in nature. Such
 forward-looking statements are subject to risks and uncertainties, which
 could cause actual results to differ materially from estimated results.
 Management cautions that all statements as to future results of operations
 are necessarily subject to risks, uncertainties, and events that may be
 beyond the control of AVVAA World Health Care Products, Inc. and no
 assurance can be given that such results will be achieved. Potential risks
 and uncertainties include but are not limited to the ability to procure,
 properly price, retain, and successfully complete projects, the
 availability of technical personnel, changes in technology, and

SOURCE avVaa World Health Care Products Inc.